Arzu Karakurt

638 total citations
33 papers, 549 citations indexed

About

Arzu Karakurt is a scholar working on Organic Chemistry, Computational Theory and Mathematics and Pharmacology. According to data from OpenAlex, Arzu Karakurt has authored 33 papers receiving a total of 549 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Organic Chemistry, 11 papers in Computational Theory and Mathematics and 10 papers in Pharmacology. Recurrent topics in Arzu Karakurt's work include Synthesis and biological activity (16 papers), Computational Drug Discovery Methods (11 papers) and Synthesis and Biological Evaluation (8 papers). Arzu Karakurt is often cited by papers focused on Synthesis and biological activity (16 papers), Computational Drug Discovery Methods (11 papers) and Synthesis and Biological Evaluation (8 papers). Arzu Karakurt collaborates with scholars based in Türkiye, United States and United Kingdom. Arzu Karakurt's co-authors include Sevim Dalkara, James P. Stables, Meral Özalp, Suat Sarı, Süheyla Özbey, Zeynep Özdemir, Engin Kendi, Mehmet Abdullah Alagöz, F.B. Kaynak and Ünsal Çalış and has published in prestigious journals such as SHILAP Revista de lepidopterología, European Journal of Medicinal Chemistry and Bioorganic & Medicinal Chemistry.

In The Last Decade

Arzu Karakurt

31 papers receiving 545 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Arzu Karakurt Türkiye 14 438 152 99 97 52 33 549
Om Silakari India 11 224 0.5× 188 1.2× 109 1.1× 109 1.1× 19 0.4× 32 446
Vinod G. Ugale India 15 437 1.0× 211 1.4× 75 0.8× 75 0.8× 12 0.2× 39 599
Ünsal Çalış Türkiye 14 698 1.6× 173 1.1× 66 0.7× 162 1.7× 19 0.4× 28 819
Maria Rosa Buemi Italy 15 257 0.6× 298 2.0× 74 0.7× 100 1.0× 70 1.3× 23 618
Mohammed Farrag El‐Behairy Egypt 12 212 0.5× 180 1.2× 42 0.4× 58 0.6× 25 0.5× 39 430
Luciana Gavernet Argentina 17 236 0.5× 243 1.6× 155 1.6× 72 0.7× 43 0.8× 44 552
Carolina L. Bellera Argentina 14 187 0.4× 181 1.2× 222 2.2× 30 0.3× 51 1.0× 30 512
Shashikant V. Bhandari India 13 631 1.4× 154 1.0× 90 0.9× 107 1.1× 33 0.6× 44 747
Georgi Stavrakov Bulgaria 15 310 0.7× 140 0.9× 108 1.1× 195 2.0× 33 0.6× 31 502
Mymoona Akhtar India 10 471 1.1× 137 0.9× 70 0.7× 80 0.8× 10 0.2× 20 618

Countries citing papers authored by Arzu Karakurt

Since Specialization
Citations

This map shows the geographic impact of Arzu Karakurt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arzu Karakurt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arzu Karakurt more than expected).

Fields of papers citing papers by Arzu Karakurt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arzu Karakurt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arzu Karakurt. The network helps show where Arzu Karakurt may publish in the future.

Co-authorship network of co-authors of Arzu Karakurt

This figure shows the co-authorship network connecting the top 25 collaborators of Arzu Karakurt. A scholar is included among the top collaborators of Arzu Karakurt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arzu Karakurt. Arzu Karakurt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Özdemir, Zeynep, Arzu Karakurt, Suat Sarı, et al.. (2024). Potent Antimicrobial Azoles: Synthesis, In Vitro and In Silico Study. Antibiotics. 13(11). 1044–1044.
2.
Sarı, Suat, et al.. (2023). Azole derivatives inhibit wildtype butyrylcholinesterase and its common mutants. Drug Development Research. 84(5). 1018–1028. 1 indexed citations
3.
Sarı, Suat, Suna Sabuncuoğlu, Zeynep Özdemir, et al.. (2022). Antifungal Azole Derivatives Featuring Naphthalene Prove Potent and Competitive Cholinesterase Inhibitors with Potential CNS Penetration According to the in Vitro and in Silico Studies. Chemistry & Biodiversity. 19(7). e202200027–e202200027. 7 indexed citations
4.
Gambacorta, Nicola, Zeynep Özdemir, Fulvio Ciriaco, et al.. (2022). Integrated experimental and theoretical approaches to investigate the molecular mechanisms of the enantioseparation of chiral anticonvulsant and antifungal compounds. Journal of Molecular Structure. 1270. 133905–133905. 2 indexed citations
5.
Özdemir, Zeynep, et al.. (2022). Cytotoxic effect of azole compounds bearing trifluorophenyl ring on MCF-7, MDA-MB-231, and HCT-116 cancer cell line. Medicine Science | International Medical Journal. 11(3). 1212–1212. 1 indexed citations
6.
Alagöz, Mehmet Abdullah, Arzu Karakurt, Ceylan Hepokur, et al.. (2021). Synthesis of New 1-Aryl-2-(3,5-dimethylpyrazol-1-yl)ethanone Oxime Ether Derivatives and Investigation of Their Cytotoxic Effects. Processes. 9(11). 2019–2019. 2 indexed citations
7.
Özdemir, Zeynep, et al.. (2020). Synthesis, molecular modelling and biological activity of some pyridazinone derivatives as selective human monoamine oxidase-B inhibitors. Pharmacological Reports. 72(3). 692–704. 15 indexed citations
8.
9.
Sarı, Suat, Didem Kart, Naile Öztürk, et al.. (2019). Discovery of new azoles with potent activity against Candida spp. and Candida albicans biofilms through virtual screening. European Journal of Medicinal Chemistry. 179. 634–648. 16 indexed citations
10.
Sarı, Suat, Didem Kart, Suna Sabuncuoğlu, et al.. (2019). Antifungal screening and in silico mechanistic studies of an in‐house azole library. Chemical Biology & Drug Design. 94(5). 1944–1955. 7 indexed citations
11.
Karakurt, Arzu, et al.. (2018). Parenteral systemic antifungal drugs and their clinical drug informations. SHILAP Revista de lepidopterología. 1–1. 2 indexed citations
12.
Sarı, Suat, Arzu Karakurt, Harun Uslu, et al.. (2016). New (arylalkyl)azole derivatives showing anticonvulsant effects could have VGSC and/or GABA A R affinity according to molecular modeling studies. European Journal of Medicinal Chemistry. 124. 407–416. 22 indexed citations
13.
Karataş, Mert Olgun, Harun Uslu, Suat Sarı, et al.. (2015). Coumarin or benzoxazinone based novel carbonic anhydrase inhibitors: synthesis, molecular docking and anticonvulsant studies. Journal of Enzyme Inhibition and Medicinal Chemistry. 31(5). 760–772. 36 indexed citations
14.
Özdemir, Zeynep, Arzu Karakurt, Ünsal Çalış, et al.. (2014). Synthesis, Anticonvulsant and Antimicrobial Activities of Some New [1-(2-Naphthyl)-2-(pyrazol-1-yl)ethanone]oxime Ethers. Medicinal Chemistry. 11(1). 41–49. 16 indexed citations
15.
Şahin, Zarife Sibel, et al.. (2012). An X-ray and DFT Computational Study on 1-（Naphthalene-2-yl）-2-（1H-pyrazol-1-yl） ethanone O-butyl Oxime. 结构化学. 31(2). 262–270. 1 indexed citations
16.
Kamışlı, Suat, et al.. (2012). Evaluation of the Effects of Novel Nafimidone Derivatives on Thermal Hypoalgesia in Mice with Diabetic Neuropathy. Balkan Medical Journal. 30(1). 94–98. 1 indexed citations
17.
18.
Karakurt, Arzu, et al.. (2012). Synthesis of some novel 1-(2-naphthyl)-2-(imidazol-1-yl)ethanone oxime ester derivatives and evaluation of their anticonvulsant activity. European Journal of Medicinal Chemistry. 57. 275–282. 46 indexed citations
19.
Karakurt, Arzu, Meral Özalp, Ş. Işık, James P. Stables, & Sevim Dalkara. (2010). Synthesis, anticonvulsant and antimicrobial activities of some new 2-acetylnaphthalene derivatives. Bioorganic & Medicinal Chemistry. 18(8). 2902–2911. 64 indexed citations
20.
Karakurt, Arzu, Sevim Dalkara, Meral Özalp, et al.. (2001). Synthesis of some 1-(2-naphthyl)-2-(imidazole-1-yl)ethanone oxime and oxime ether derivatives and their anticonvulsant and antimicrobial activities. European Journal of Medicinal Chemistry. 36(5). 421–433. 103 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Om Silakari Breakdown of academic impact, for papers by Vinod G. Ugale Breakdown of academic impact, for papers by Ünsal Çalış Breakdown of academic impact, for papers by Maria Rosa Buemi Breakdown of academic impact, for papers by Mohammed Farrag El‐Behairy Breakdown of academic impact, for papers by Luciana Gavernet Breakdown of academic impact, for papers by Carolina L. Bellera Breakdown of academic impact, for papers by Shashikant V. Bhandari Breakdown of academic impact, for papers by Georgi Stavrakov Breakdown of academic impact, for papers by Mymoona Akhtar
Rankless by CCL
2026